NEW YORK--(BUSINESS WIRE)--American Oriental Bioengineering Inc. (AMEX: AOB) Third Quarter 2006 Highlights: Organic Revenue Growth of 63% during the Quarter Consolidated Gross Margins improve 3.5% versus last year to 66.9% Management Expects Fourth Quarter Revenue to be in the range of $37 million to $39 million and at least $0.15 in EPS
